Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). (Q39779618)

14 September 2017

title

Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). (English)

1 reference

14 September 2017

Lucie Chevillard

2

0 references

Nicolas Tournier

object named as

Nicolas Tournier

1

0 references

Bruno Mégarbane

3

object named as

Bruno Megarbane

1 reference

14 September 2017

Jean-Michel Scherrmann

5

object named as

Jean-Michel Scherrmann

1 reference

14 September 2017

Stéphane Pirnay

4

1 reference

14 September 2017

Xavier Declèves

6

1 reference

14 September 2017

language of work or name

1 reference

4 November 2009

1 reference

The International Journal of Neuropsychopharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

13

1 reference

14 September 2017

issue

7

1 reference

14 September 2017

page(s)

905-915

1 reference

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Expression and function of multidrug resistance transporters at the blood-brain barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Variable modulation of opioid brain uptake by P-glycoprotein in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Increased drug delivery to the brain by P-glycoprotein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

pH dependent efflux of methamphetamine derivatives and their reversal through human Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Pheophorbide a is a specific probe for ABCG2 function and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Interactions between recreational drugs and antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

MDR- and CYP3A4-mediated drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Role of P-glycoprotein in transplacental transfer of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

P-glycoprotein does not actively transport nicotine and cotinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Clinical pharmacology of buprenorphine: ceiling effects at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

No Influence of ABCB1 Haplotypes on Methadone Dosage Requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

7 January 2021

Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

7 January 2021

Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

7 January 2021

Communication between multiple drug binding sites on P-glycoprotein

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

7 January 2021

Role of pharmacogenetics in variable response to drugs: focus on opioids

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990848

7 January 2021

10.1017/S1461145709990848

Identifiers

DOI

1 reference

14 September 2017

1 reference